Massive transfusion coagulopathy

被引:62
作者
Levy, JH [1 ]
机构
[1] Emory Univ, Sch Med Cardiothorac Anesthesiol & Crit Care, Dept Anesthesiol, Emory Healthcare, Atlanta, GA 30322 USA
关键词
D O I
10.1053/j.seminhematol.2005.11.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S59 / S63
页数:5
相关论文
共 41 条
[1]  
BECKER EL, 1977, ARCH PATHOL LAB MED, V101, P509
[2]  
CHINOHARA M, 1997, RINSHO BYORI, V45, P179
[3]   Does clopidogrel increase blood loss following coronary artery bypass surgery? [J].
Chu, MWA ;
Wilson, SR ;
Novick, RJ ;
Stitt, LW ;
Quantz, MA .
ANNALS OF THORACIC SURGERY, 2004, 78 (05) :1536-1541
[4]   Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis [J].
Collett, JP ;
Montalescot, G ;
Lesty, C ;
Soria, J ;
Mishal, Z ;
Thoms, D ;
Soria, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (01) :142-148
[5]   A risk-benefit assessment of aprotinin in cardiac surgical procedures [J].
Dobkowski, WB ;
Murkin, JM .
DRUG SAFETY, 1998, 18 (01) :21-41
[6]   Tranexamic acid - A review of its use in surgery and other indications [J].
Dunn, CJ ;
Goa, KL .
DRUGS, 1999, 57 (06) :1005-1032
[7]   Recombinant activated factor VIIa use in massive transfusion and Coagulopathy unresponsive to conventional therapy [J].
Gowers, CJD ;
Parr, MJA .
ANAESTHESIA AND INTENSIVE CARE, 2005, 33 (02) :196-200
[8]   Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery [J].
Halkos, ME ;
Levy, JH ;
Chen, E ;
Reddy, S ;
Lattouf, OM ;
Guyton, RA ;
Song, HK .
ANNALS OF THORACIC SURGERY, 2005, 79 (04) :1303-1306
[9]   Massive transfusion and coagulopathy: pathophysiology and implications for clinical management [J].
Hardy, JF ;
de Moerloose, P ;
Samama, M .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2004, 51 (04) :293-310
[10]   Hemostasis during normal pregnancy and puerperium [J].
Hellgren, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 (02) :125-130